Citius Pharmaceuticals, Inc. (CTXR)
NASDAQ: CTXR · Real-Time Price · USD
1.800
-0.050 (-2.70%)
At close: Feb 21, 2025, 4:00 PM
1.780
-0.020 (-1.11%)
After-hours: Feb 21, 2025, 6:11 PM EST
Citius Pharmaceuticals Employees
Citius Pharmaceuticals had 23 employees as of September 30, 2024. The number of employees increased by 1 or 4.55% compared to the previous year.
Employees
23
Change (1Y)
1
Growth (1Y)
4.55%
Revenue / Employee
n/a
Profits / Employee
-$1,770,574
Market Cap
15.47M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 440,000 |
| Johnson & Johnson | 131,900 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 72,000 |
CTXR News
- 7 days ago - Citius Pharmaceuticals, Inc. Reports Fiscal First Quarter 2025 Financial Results and Provides Business Update - PRNewsWire
- 16 days ago - Citius Pharmaceuticals and Citius Oncology Announce Unique Permanent J-Code Issued for LYMPHIR by Centers for Medicare and Medicaid Services - PRNewsWire
- 6 weeks ago - Citius Pharmaceuticals Announces $3 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules - PRNewsWire
- 6 weeks ago - Citius Pharmaceuticals and Citius Oncology Highlight LYMPHIR Commercial Launch Planned for the First Half of 2025 - PRNewsWire
- 6 weeks ago - Citius Oncology Engages Jefferies as Exclusive Financial Advisor to Explore Strategic Alternatives - PRNewsWire
- 2 months ago - Citius Pharmaceuticals, Inc. Reports Fiscal Full Year 2024 Financial Results and Provides Business Update - PRNewsWire
- 3 months ago - Citius Pharmaceuticals Reports Productive FDA Type C Meeting to Discuss Phase 3 Mino-Lok® Program and Pathway to Approval - PRNewsWire
- 3 months ago - Citius Pharmaceuticals, Inc. Announces 1-for-25 Reverse Stock Split - PRNewsWire